STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #774 by analyst upside · 2026-06-27
TLRY
Tilray Brands, Inc.
Healthcare · Market Cap $561M · P/E 0x
ANALYST PRICE TARGET
+108.1%
implied upside to consensus target
Current Price $4.64
Consensus Target $9.66
Bull Target $24.0
Bear Target $6.5
Analysts Covering 9
ANALYST CONSENSUS — HOLD
Strong Buy
0
Buy
2
Hold
6
Sell
1
52-Week Low $3.9
52-Week High $23.2
YTD Return -52.3%
FUNDAMENTALS
Market Cap $561M
P/E Ratio (TTM) N/A
Forward P/E 17.1x
EPS (TTM) $-14.63
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $858M
Profit Margin -156.7%
52-WEEK RANGE
52-Week Low $3.9
52-Week High $23.2
Current Price $4.64
Bear Target $6.5
Bull Target $24.0
● Now $4.64 ● Target $9.66
TRADING DATA
Avg Volume 4.9M
YTD Return -52.3%
Analyst Count 9
Consensus Hold
Upside to Target +108.1%
Last Updated 2026-06-27

ANALYST SUMMARY

Tilray Brands, Inc. (TLRY) is currently trading at $4.64 with a Wall Street consensus price target of $9.66, implying potential upside of 108.1% over the next 12 months. 9 analysts currently cover TLRY, with a consensus rating of Hold — 22% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $24.0, while the most cautious has a target of $6.5.

TLRY operates in the Healthcare sector with a market capitalisation of $561M. The stock is down 52.3% year-to-date and is currently trading near the lower end of its 52-week range of $3.9 – $23.2.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for TLRY, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Roth Capital ↑ Upgrade
Neutral → Buy 2026-04-02 Building track record
TD Cowen — Reiterated
Buy → Buy 2026-03-30 Building track record
Roth Capital — Reiterated
Neutral → Neutral 2026-01-20 Building track record
Jefferies — Reiterated
Buy → Buy 2025-08-25 50% win rate (6 calls)
Zelman & Assoc reit
Neutral → Neutral 2025-07-29 Building track record
Piper Sandler — Reiterated
Neutral → Neutral 2025-04-09 14% win rate (7 calls)
Roth MKM — Reiterated
Neutral → Neutral 2024-10-11 25% win rate (12 calls)
Zuanic & Associates ● Initiated
Neutral 2024-06-27 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
out of 100
Coverage depth
0/30
Consensus clarity
0/30
Vote unanimity
0/25
Rating stability
0/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call — not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →